"Monophenol Monooxygenase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1.
| Descriptor ID |
D014442
|
| MeSH Number(s) |
D08.811.682.690.708.125.500
|
| Concept/Terms |
Monophenol Monooxygenase- Monophenol Monooxygenase
- Monooxygenase, Monophenol
- Dopa Oxidase
- Oxidase, Dopa
- Phenol Oxidase
- Oxidase, Phenol
- Phenoloxidase
- Tyrosinase
- Cresolase
|
Below are MeSH descriptors whose meaning is more general than "Monophenol Monooxygenase".
Below are MeSH descriptors whose meaning is more specific than "Monophenol Monooxygenase".
This graph shows the total number of publications written about "Monophenol Monooxygenase" by people in this website by year, and whether "Monophenol Monooxygenase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Monophenol Monooxygenase" by people in Profiles.
-
Smith KER, Peng KW, Pulido JS, Weisbrod AJ, Strand CA, Allred JB, Newsom AN, Zhang L, Packiriswamy N, Kottke T, Tonne JM, Moore M, Montane HN, Kottschade LA, McWilliams RR, Dudek AZ, Yan Y, Dimou A, Markovic SN, Federspiel MJ, Vile RG, Dronca RS, Block MS. A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses. Front Immunol. 2023; 14:1279387.
-
Sciancalepore AG, Polini A, Mele E, Girardo S, Cingolani R, Pisignano D. Rapid nested-PCR for tyrosinase gene detection on chip. Biosens Bioelectron. 2011 Jan 15; 26(5):2711-5.
-
Kandavelou K, Ramalingam S, London V, Mani M, Wu J, Alexeev V, Civin CI, Chandrasegaran S. Targeted manipulation of mammalian genomes using designed zinc finger nucleases. Biochem Biophys Res Commun. 2009 Oct 09; 388(1):56-61.
-
Thangasamy T, Sittadjody S, Lanza-Jacoby S, Wachsberger PR, Limesand KH, Burd R. Quercetin selectively inhibits bioreduction and enhances apoptosis in melanoma cells that overexpress tyrosinase. Nutr Cancer. 2007; 59(2):258-68.
-
Alexeev V, Igoucheva O, Yoon K. Simultaneous targeted alteration of the tyrosinase and c-kit genes by single-stranded oligonucleotides. Gene Ther. 2002 Dec; 9(24):1667-75.
-
Miettinen M, Fernandez M, Franssila K, Gatalica Z, Lasota J, Sarlomo-Rikala M. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers. Am J Surg Pathol. 2001 Feb; 25(2):205-11.
-
Alexeev V, Yoon K. Gene correction by RNA-DNA oligonucleotides. Pigment Cell Res. 2000 Apr; 13(2):72-9.
-
Alexeev V, Igoucheva O, Domashenko A, Cotsarelis G, Yoon K. Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide. Nat Biotechnol. 2000 Jan; 18(1):43-7.
-
Rice DS, Goldowitz D, Williams RW, Hamre K, Johnson PT, Tan SS, Reese BE. Extrinsic modulation of retinal ganglion cell projections: analysis of the albino mutation in pigmentation mosaic mice. Dev Biol. 1999 Dec 01; 216(1):41-56.
-
Kuhn JA, McCarty TM. Malignant melanoma and the sentinel lymph node biopsy. Cancer Invest. 1999; 17(1):39-46.